# AET02 variant 1 is produced correctly

    Code
      res
    Output
                                                                   A: Drug X    B: Placebo    C: Combination   All Patients
                                                                    (N=134)       (N=134)        (N=132)         (N=400)   
      —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event     122 (91%)    123 (91.8%)    120 (90.9%)     365 (91.2%) 
      Overall total number of events                                  609           622            703             1934    
      cl A.1                                                                                                               
        Total number of patients with at least one adverse event   78 (58.2%)    75 (56%)       89 (67.4%)     242 (60.5%) 
        Total number of events                                        132           130            160             422     
        dcd A.1.1.1.1                                              50 (37.3%)   45 (33.6%)      63 (47.7%)     158 (39.5%) 
        dcd A.1.1.1.2                                              48 (35.8%)   48 (35.8%)      50 (37.9%)     146 (36.5%) 
      cl B.2                                                                                                               
        Total number of patients with at least one adverse event    79 (59%)    74 (55.2%)      85 (64.4%)     238 (59.5%) 
        Total number of events                                        129           138            143             410     
        dcd B.2.2.3.1                                              48 (35.8%)   54 (40.3%)      51 (38.6%)     153 (38.2%) 
        dcd B.2.1.2.1                                              49 (36.6%)   44 (32.8%)      52 (39.4%)     145 (36.2%) 
      cl D.1                                                                                                               
        Total number of patients with at least one adverse event    79 (59%)     67 (50%)       80 (60.6%)     226 (56.5%) 
        Total number of events                                        127           106            135             368     
        dcd D.1.1.1.1                                              50 (37.3%)   42 (31.3%)      51 (38.6%)     143 (35.8%) 
        dcd D.1.1.4.2                                              48 (35.8%)   42 (31.3%)      50 (37.9%)     140 (35.0%) 
      cl D.2                                                                                                               
        Total number of patients with at least one adverse event   47 (35.1%)   58 (43.3%)      57 (43.2%)     162 (40.5%) 
        Total number of events                                         62           72              74             208     
        dcd D.2.1.5.3                                              47 (35.1%)   58 (43.3%)      57 (43.2%)     162 (40.5%) 
      cl B.1                                                                                                               
        Total number of patients with at least one adverse event   47 (35.1%)   49 (36.6%)      43 (32.6%)     139 (34.8%) 
        Total number of events                                         56           60              62             178     
        dcd B.1.1.1.1                                              47 (35.1%)   49 (36.6%)      43 (32.6%)     139 (34.8%) 
      cl C.2                                                                                                               
        Total number of patients with at least one adverse event   35 (26.1%)   48 (35.8%)      55 (41.7%)     138 (34.5%) 
        Total number of events                                         48           53              65             166     
        dcd C.2.1.2.1                                              35 (26.1%)   48 (35.8%)      55 (41.7%)     138 (34.5%) 
      cl C.1                                                                                                               
        Total number of patients with at least one adverse event   43 (32.1%)   46 (34.3%)      43 (32.6%)      132 (33%)  
        Total number of events                                         55           63              64             182     
        dcd C.1.1.1.3                                              43 (32.1%)   46 (34.3%)      43 (32.6%)     132 (33.0%) 

# AET02 variant 2 is produced correctly

    Code
      res
    Output
                                                                   A: Drug X    B: Placebo    C: Combination   All Patients
                                                                    (N=134)       (N=134)        (N=132)         (N=400)   
      —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event     122 (91%)    123 (91.8%)    120 (90.9%)     365 (91.2%) 
      Overall total number of events                                  609           622            703             1934    
      cl A.1                                                                                                               
        Total number of patients with at least one adverse event   78 (58.2%)    75 (56%)       89 (67.4%)     242 (60.5%) 
        dcd A.1.1.1.1                                              50 (37.3%)   45 (33.6%)      63 (47.7%)     158 (39.5%) 
        dcd A.1.1.1.2                                              48 (35.8%)   48 (35.8%)      50 (37.9%)     146 (36.5%) 
        Total number of events                                        132           130            160             422     
      cl B.2                                                                                                               
        Total number of patients with at least one adverse event    79 (59%)    74 (55.2%)      85 (64.4%)     238 (59.5%) 
        dcd B.2.2.3.1                                              48 (35.8%)   54 (40.3%)      51 (38.6%)     153 (38.2%) 
        dcd B.2.1.2.1                                              49 (36.6%)   44 (32.8%)      52 (39.4%)     145 (36.2%) 
        Total number of events                                        129           138            143             410     
      cl D.1                                                                                                               
        Total number of patients with at least one adverse event    79 (59%)     67 (50%)       80 (60.6%)     226 (56.5%) 
        dcd D.1.1.1.1                                              50 (37.3%)   42 (31.3%)      51 (38.6%)     143 (35.8%) 
        dcd D.1.1.4.2                                              48 (35.8%)   42 (31.3%)      50 (37.9%)     140 (35.0%) 
        Total number of events                                        127           106            135             368     
      cl D.2                                                                                                               
        Total number of patients with at least one adverse event   47 (35.1%)   58 (43.3%)      57 (43.2%)     162 (40.5%) 
        dcd D.2.1.5.3                                              47 (35.1%)   58 (43.3%)      57 (43.2%)     162 (40.5%) 
        Total number of events                                         62           72              74             208     
      cl B.1                                                                                                               
        Total number of patients with at least one adverse event   47 (35.1%)   49 (36.6%)      43 (32.6%)     139 (34.8%) 
        dcd B.1.1.1.1                                              47 (35.1%)   49 (36.6%)      43 (32.6%)     139 (34.8%) 
        Total number of events                                         56           60              62             178     
      cl C.2                                                                                                               
        Total number of patients with at least one adverse event   35 (26.1%)   48 (35.8%)      55 (41.7%)     138 (34.5%) 
        dcd C.2.1.2.1                                              35 (26.1%)   48 (35.8%)      55 (41.7%)     138 (34.5%) 
        Total number of events                                         48           53              65             166     
      cl C.1                                                                                                               
        Total number of patients with at least one adverse event   43 (32.1%)   46 (34.3%)      43 (32.6%)      132 (33%)  
        dcd C.1.1.1.3                                              43 (32.1%)   46 (34.3%)      43 (32.6%)     132 (33.0%) 
        Total number of events                                         55           63              64             182     

# AET02 variant 3 is produced correctly

    Code
      res
    Output
                                                                     A: Drug X    B: Placebo    C: Combination
                                                                      (N=134)       (N=134)        (N=132)    
      ————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event       122 (91%)    123 (91.8%)    120 (90.9%)  
      Overall total number of events                                    609           622            703      
      cl A.1                                                                                                  
        Total number of patients with at least one adverse event     78 (58.2%)    75 (56%)       89 (67.4%)  
        Total number of events                                          132           130            160      
        hlt A.1.1.1                                                                                           
          Total number of patients with at least one adverse event   78 (58.2%)    75 (56%)       89 (67.4%)  
          Total number of events                                        132           130            160      
          dcd A.1.1.1.1                                              50 (37.3%)   45 (33.6%)      63 (47.7%)  
          dcd A.1.1.1.2                                              48 (35.8%)   48 (35.8%)      50 (37.9%)  
      cl B.2                                                                                                  
        Total number of patients with at least one adverse event      79 (59%)    74 (55.2%)      85 (64.4%)  
        Total number of events                                          129           138            143      
        hlt B.2.2.3                                                                                           
          Total number of patients with at least one adverse event   48 (35.8%)   54 (40.3%)      51 (38.6%)  
          Total number of events                                         64           76              77      
          dcd B.2.2.3.1                                              48 (35.8%)   54 (40.3%)      51 (38.6%)  
        hlt B.2.1.2                                                                                           
          Total number of patients with at least one adverse event   49 (36.6%)   44 (32.8%)      52 (39.4%)  
          Total number of events                                         65           62              66      
          dcd B.2.1.2.1                                              49 (36.6%)   44 (32.8%)      52 (39.4%)  
      cl D.1                                                                                                  
        Total number of patients with at least one adverse event      79 (59%)     67 (50%)       80 (60.6%)  
        Total number of events                                          127           106            135      
        hlt D.1.1.1                                                                                           
          Total number of patients with at least one adverse event   50 (37.3%)   42 (31.3%)      51 (38.6%)  
          Total number of events                                         61           51              71      
          dcd D.1.1.1.1                                              50 (37.3%)   42 (31.3%)      51 (38.6%)  
        hlt D.1.1.4                                                                                           
          Total number of patients with at least one adverse event   48 (35.8%)   42 (31.3%)      50 (37.9%)  
          Total number of events                                         66           55              64      
          dcd D.1.1.4.2                                              48 (35.8%)   42 (31.3%)      50 (37.9%)  
      cl D.2                                                                                                  
        Total number of patients with at least one adverse event     47 (35.1%)   58 (43.3%)      57 (43.2%)  
        Total number of events                                           62           72              74      
        hlt D.2.1.5                                                                                           
          Total number of patients with at least one adverse event   47 (35.1%)   58 (43.3%)      57 (43.2%)  
          Total number of events                                         62           72              74      
          dcd D.2.1.5.3                                              47 (35.1%)   58 (43.3%)      57 (43.2%)  
      cl B.1                                                                                                  
        Total number of patients with at least one adverse event     47 (35.1%)   49 (36.6%)      43 (32.6%)  
        Total number of events                                           56           60              62      
        hlt B.1.1.1                                                                                           
          Total number of patients with at least one adverse event   47 (35.1%)   49 (36.6%)      43 (32.6%)  
          Total number of events                                         56           60              62      
          dcd B.1.1.1.1                                              47 (35.1%)   49 (36.6%)      43 (32.6%)  
      cl C.2                                                                                                  
        Total number of patients with at least one adverse event     35 (26.1%)   48 (35.8%)      55 (41.7%)  
        Total number of events                                           48           53              65      
        hlt C.2.1.2                                                                                           
          Total number of patients with at least one adverse event   35 (26.1%)   48 (35.8%)      55 (41.7%)  
          Total number of events                                         48           53              65      
          dcd C.2.1.2.1                                              35 (26.1%)   48 (35.8%)      55 (41.7%)  
      cl C.1                                                                                                  
        Total number of patients with at least one adverse event     43 (32.1%)   46 (34.3%)      43 (32.6%)  
        Total number of events                                           55           63              64      
        hlt C.1.1.1                                                                                           
          Total number of patients with at least one adverse event   43 (32.1%)   46 (34.3%)      43 (32.6%)  
          Total number of events                                         55           63              64      
          dcd C.1.1.1.3                                              43 (32.1%)   46 (34.3%)      43 (32.6%)  

# AET02 variant 4 is produced correctly

    Code
      res
    Output
                                                                 A: Drug X    B: Placebo    C: Combination
                                                                  (N=134)       (N=134)        (N=132)    
      ————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event   122 (91%)    123 (91.8%)    120 (90.9%)  
      Total number of events                                        609           622            703      
      dcd D.2.1.5.3                                              47 (35.1%)   58 (43.3%)      57 (43.2%)  
      dcd A.1.1.1.1                                              50 (37.3%)   45 (33.6%)      63 (47.7%)  
      dcd B.2.2.3.1                                              48 (35.8%)   54 (40.3%)      51 (38.6%)  
      dcd A.1.1.1.2                                              48 (35.8%)   48 (35.8%)      50 (37.9%)  
      dcd B.2.1.2.1                                              49 (36.6%)   44 (32.8%)      52 (39.4%)  
      dcd D.1.1.1.1                                              50 (37.3%)   42 (31.3%)      51 (38.6%)  
      dcd D.1.1.4.2                                              48 (35.8%)   42 (31.3%)      50 (37.9%)  
      dcd B.1.1.1.1                                              47 (35.1%)   49 (36.6%)      43 (32.6%)  
      dcd C.2.1.2.1                                              35 (26.1%)   48 (35.8%)      55 (41.7%)  
      dcd C.1.1.1.3                                              43 (32.1%)   46 (34.3%)      43 (32.6%)  

# AET02 variant 5 is produced correctly

    Code
      res
    Output
                                                                   A: Drug X    B: Placebo    C: Combination
                                                                    (N=134)       (N=134)        (N=132)    
      ——————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event     122 (91%)    123 (91.8%)         0       
      Overall total number of events                                  609           622             0       
      cl A.1                                                                                                
        Total number of patients with at least one adverse event   78 (58.2%)    75 (56%)           0       
        Total number of events                                        132           130             0       
        dcd A.1.1.1.2                                              48 (35.8%)   48 (35.8%)          0       
        dcd A.1.1.1.1                                              50 (37.3%)   45 (33.6%)          0       
      cl B.2                                                                                                
        Total number of patients with at least one adverse event    79 (59%)    74 (55.2%)          0       
        Total number of events                                        129           138             0       
        dcd B.2.2.3.1                                              48 (35.8%)   54 (40.3%)          0       
        dcd B.2.1.2.1                                              49 (36.6%)   44 (32.8%)          0       
      cl D.1                                                                                                
        Total number of patients with at least one adverse event    79 (59%)     67 (50%)           0       
        Total number of events                                        127           106             0       
        dcd D.1.1.1.1                                              50 (37.3%)   42 (31.3%)          0       
        dcd D.1.1.4.2                                              48 (35.8%)   42 (31.3%)          0       
      cl D.2                                                                                                
        Total number of patients with at least one adverse event   47 (35.1%)   58 (43.3%)          0       
        Total number of events                                         62           72              0       
        dcd D.2.1.5.3                                              47 (35.1%)   58 (43.3%)          0       
      cl B.1                                                                                                
        Total number of patients with at least one adverse event   47 (35.1%)   49 (36.6%)          0       
        Total number of events                                         56           60              0       
        dcd B.1.1.1.1                                              47 (35.1%)   49 (36.6%)          0       
      cl C.1                                                                                                
        Total number of patients with at least one adverse event   43 (32.1%)   46 (34.3%)          0       
        Total number of events                                         55           63              0       
        dcd C.1.1.1.3                                              43 (32.1%)   46 (34.3%)          0       
      cl C.2                                                                                                
        Total number of patients with at least one adverse event   35 (26.1%)   48 (35.8%)          0       
        Total number of events                                         48           53              0       
        dcd C.2.1.2.1                                              35 (26.1%)   48 (35.8%)          0       

# AET02 variant 6 is produced correctly

    Code
      res
    Output
                          A: Drug X    B: Placebo   C: Combination
                           (N=134)      (N=134)        (N=132)    
      ————————————————————————————————————————————————————————————
      cl A.1                                                      
          dcd A.1.1.1.1   50 (37.3%)   45 (33.6%)     63 (47.7%)  
      cl B.2                                                      
          dcd B.2.2.3.1   48 (35.8%)   54 (40.3%)     51 (38.6%)  
      cl D.2                                                      
          dcd D.2.1.5.3   47 (35.1%)   58 (43.3%)     57 (43.2%)  
      cl C.2                                                      
          dcd C.2.1.2.1   35 (26.1%)   48 (35.8%)     55 (41.7%)  

# AET02 variant 7 is produced correctly

    Code
      res
    Output
                        A: Drug X    B: Placebo   C: Combination
                         (N=134)      (N=134)        (N=132)    
      ——————————————————————————————————————————————————————————
      cl A.1                                                    
      hlt A.1.1.1                                               
        dcd A.1.1.1.1   50 (37.3%)   45 (33.6%)     63 (47.7%)  
      cl B.2                                                    
      hlt B.2.2.3                                               
        dcd B.2.2.3.1   48 (35.8%)   54 (40.3%)     51 (38.6%)  
      cl D.2                                                    
      hlt D.2.1.5                                               
        dcd D.2.1.5.3   47 (35.1%)   58 (43.3%)     57 (43.2%)  
      cl C.2                                                    
      hlt C.2.1.2                                               
        dcd C.2.1.2.1   35 (26.1%)   48 (35.8%)     55 (41.7%)  

# AET02 variant 8 is produced correctly

    Code
      res
    Output
                          A: Drug X    B: Placebo   C: Combination
                           (N=134)      (N=134)        (N=132)    
      ————————————————————————————————————————————————————————————
      cl A.1                                                      
          dcd A.1.1.1.1   50 (37.3%)   45 (33.6%)     63 (47.7%)  
      cl B.2                                                      
          dcd B.2.2.3.1   48 (35.8%)   54 (40.3%)     51 (38.6%)  
      cl D.2                                                      
          dcd D.2.1.5.3   47 (35.1%)   58 (43.3%)     57 (43.2%)  
      cl C.2                                                      
          dcd C.2.1.2.1   35 (26.1%)   48 (35.8%)     55 (41.7%)  

# AET02 variant 9 is produced correctly

    Code
      res
    Output
                          A: Drug X    B: Placebo   C: Combination
                           (N=134)      (N=134)        (N=132)    
      ————————————————————————————————————————————————————————————
      cl A.1                                                      
          dcd A.1.1.1.1   50 (37.3%)   45 (33.6%)     63 (47.7%)  
      cl B.2                                                      
          dcd B.2.2.3.1   48 (35.8%)   54 (40.3%)     51 (38.6%)  
          dcd B.2.1.2.1   49 (36.6%)   44 (32.8%)     52 (39.4%)  
      cl D.2                                                      
          dcd D.2.1.5.3   47 (35.1%)   58 (43.3%)     57 (43.2%)  
      cl C.2                                                      
          dcd C.2.1.2.1   35 (26.1%)   48 (35.8%)     55 (41.7%)  

# AET02 variant 10 is produced correctly

    Code
      res
    Output
                          A: Drug X    B: Placebo   C: Combination
                           (N=134)      (N=134)        (N=132)    
      ————————————————————————————————————————————————————————————
      cl A.1                                                      
          dcd A.1.1.1.1   50 (37.3%)   45 (33.6%)     63 (47.7%)  
      cl B.2                                                      
          dcd B.2.1.2.1   49 (36.6%)   44 (32.8%)     52 (39.4%)  
      cl D.1                                                      
          dcd D.1.1.1.1   50 (37.3%)   42 (31.3%)     51 (38.6%)  
          dcd D.1.1.4.2   48 (35.8%)   42 (31.3%)     50 (37.9%)  
      cl D.2                                                      
          dcd D.2.1.5.3   47 (35.1%)   58 (43.3%)     57 (43.2%)  
      cl C.2                                                      
          dcd C.2.1.2.1   35 (26.1%)   48 (35.8%)     55 (41.7%)  

# AET02 variant 11 is produced correctly

    Code
      res
    Output
                          A: Drug X    B: Placebo   C: Combination
                           (N=134)      (N=134)        (N=132)    
      ————————————————————————————————————————————————————————————
      cl B.2                                                      
          dcd B.2.2.3.1   48 (35.8%)   54 (40.3%)     51 (38.6%)  
      cl D.2                                                      
          dcd D.2.1.5.3   47 (35.1%)   58 (43.3%)     57 (43.2%)  

# AET02 variant 12 is produced correctly

    Code
      res
    Output
                        A: Drug X    B: Placebo   C: Combination
                         (N=134)      (N=134)        (N=132)    
      ——————————————————————————————————————————————————————————
      cl A.1                                                    
        dcd A.1.1.1.1   50 (37.3%)   45 (33.6%)     63 (47.7%)  
      cl D.1                                                    
        dcd D.1.1.1.1   50 (37.3%)   42 (31.3%)     51 (38.6%)  
      cl D.2                                                    
        dcd D.2.1.5.3   47 (35.1%)   58 (43.3%)     57 (43.2%)  
      cl C.2                                                    
        dcd C.2.1.2.1   35 (26.1%)   48 (35.8%)     55 (41.7%)  

